Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HRTG | UFCS |
|---|---|---|
| Price | $34.54 | $55.05 |
| Change today | ▲ 1.08% | ▲ 0.33% |
| Market cap | $1.03B | $1.42B |
| Return, 3 months | +27.4% | +6.3% |
| Return, year to date | +18.0% | +52.7% |
| Return, 1 year | +33.2% | +79.4% |
| P/E (TTM) | 4.9 | 10.2 |
| P/B | 1.8 | 1.4 |
| P/E percentile vs own 5y | 63rd | 57th |
| Dividend yield | – | 1.31% |
| Revenue growth (YoY, latest qtr) | +3.0% | +14.0% |
| Net profit growth (YoY) | +28.5% | +45.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 27.5% | 9.6% |
| Return on equity | 45.3% | 15.5% |
| Analyst target vs. price | +5.7% | +6.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 59 | 59 |
| 30-day volatility | 20.6% | 18.4% |
| Max drawdown, 1 year | -32.9% | -12.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
